Transcept Pharmaceuticals (TSPT) Granted U.S. Patent Covering Intermezzo Formulation
Tweet Send to a Friend
Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) announced that the first patent covering the composition and method of use of Intermezzo (zolpidem ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
